See also this year's filing and all EDGAR filings for this company.
PDF Report 0001763950_2024_Lantern_Pharma_Inc.pdf
Logs
Graph
Absolute values for 0001763950, Lantern Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,341,325 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 52,127 |
| 3 | remainder_Assets | 254,164 |
| 4 | LiabilitiesCurrent | 2,678,186 |
| 5 | LiabilitiesNoncurrent | 61,496 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,925,400 |
| 9 | ResearchAndDevelopmentExpense | 13,917,109 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 191,728 |
| 13 | remainder_ComprehensiveNetIncome | -278,152 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,647,616 |
| 1 | Liabilities | 2,739,682 |
| 2 | Expenses | 19,842,509 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 40,907,934 |
| 5 | NetIncome | -19,650,781 |
| 6 | ComprehensiveNetIncome | -19,789,857 |
| 7 | BaseVar | 33,349,844 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.99 |
| 9 | EconomicCapitalRatio | 3.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
